Interleukin-1α enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells

Medical Science Monitor

Volumn 11, Issue 10, 2005, Pages

  Sawai, Hirozumi ^a   Funahashi, Hitoshi ^a   Okada, Yuji ^a   Matsuo, Yoichi ^a   Sakamoto, Masaki ^a   Yamamoto, Minoru ^a   Takeyama, Hiromitsu ^a   Manabe, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

ERK 1 2; IL 1 ; IL 8; MAPK; ROS

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; INTERLEUKIN 1;

ARTICLE; CANCER CELL; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIUM CELL; PANCREAS CANCER; PARACRINE SIGNALING; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; CULTURE MEDIUM; ENZYMOLOGY; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; SECRETION;

BLOTTING, WESTERN; CULTURE MEDIA, CONDITIONED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 26944497594     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Li D, Xie K, Wolff R, Abruzzese JL: Pancreatic cancer. Lancet 2004; 363: 1049-57
2. Wang JM, Deng X, Gong W, Su S: Cheiuokines and their role in tumor growth and metastasis. J Immunol Methods, 1998; 220: 1-17
3. Spechler SJ: The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology, 1999; 117: 218-28
4. Koch AE, Polverini PJ, Kunkel SL et al: Interleukin-8 as a niacrophagederived mediator of angiogenesis. Science, 1992; 258: 1798-801
5. Strieter RM, Polverini PJ, Arenberg DA et al: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol, 1995; 57: 752-62
6. Kitadai Y, Haruma K, Sumii K et al: Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol. 1998; 152: 93-100
7. Kitadai Y, Takahashi Y, Haruma K et al: Transfection of interleukin-8 increase angiogenesis and tumoiigenesis of human gastric carcinoma cells in nude mice. Br J Cancer, 1999; 81: 647-53
8. Murdoch C, Monk PN, Finn A: Cxc chemokine receptor expression on human endothelial cells. Cytokine, 1999; 11: 704-12
9. Salcedo R, Ponce ML, Young HA et al: Human endothelial cells express CCR2 and respond to MCP-1 direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000; 96: 34-40
10. Rennekampff HO, Hansbrough JF, Kiessig V et al: Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res, 2000; 93: 41-54
11. Heidemann J, Ogawa H, Dwinell MB et al: Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvasrular endothelial cells are mediated by CXCR2. J Biol Chem, 2003; 278: 8508-15
12. Singh RK, Varney ML: IL-8 expression in malignant melanoma: implications in growth and metastasis. Histol Histopathol, 2000; 15: 843-49
13. Klezovitch O, Edelstein C, Scann AM: Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its G-terminal domain. J Biol Chem, 2001; 276: 46864-69
14. Schwarz M, Radeke HH, Resch K, Uciechowski P: Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int, 1997; 52: 1521-31
15. Maeda S, Akanuma M, Mitsuno Y et al: Distinct mechanism of Helicobacter trylori-mediated NF-κB activation between gastric cancer cells and monocytic cells. J Biol Chem, 2001; 276: 44856-64
16. Matsuo Y, Sawai H, Funahashi H et al: Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. Pancreas, 2004; 28: 344-52
17. Wojsyk-Banaszak I, Szczapa J: Reliability of interleukin-6 and interleukin-8 in distinguishing between infectious and non-infectious respiratory disorders in neonates. Med Sci Monit, 2004; 10(Suppl.2): 36-41
18. Schandendorf D, Moller A, Algermissen B et al: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol, 1993; 151: 2667-75
19. Huang S, Mills L, Mian B et al: Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol, 2002; 161: 125-34
20. De Larco JE, Wuertz BR, Yee D et al: Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc Natl Acad Sci USA, 2003; 100: 13988-93
21. Ren Y, Poon RT, Tsui HT et al: Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res, 2003; 9: 5996-6001
22. Shi Q, Abbruzzese JL, Huang S et al: Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res, 1999; 5:3711-21
23. Voronov E, Shouval DS, Krelin Y et al: IL-1 is required for tumor invasiveness and angiogenesis. Proc Nad Acad Sci, 2003; 100: 2645-50
24. Chirivi RG, Chiodoni C, Musiani P et al: IL-1 alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice. Int J Cancer, 1996; 67: 856-63
25. Vidal-Vanaclocha F, Amezaga C, Asumendi A et al: Interleiikin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res, 1994; 54: 2667-72
26. Sawai H, Funahashi H, Yamamoto M et al: Interleukin-1α enhances integrin α6β1 expression and metastatic capability of human pancreatic cancer. Oncology, 2003; 65: 167-73
27. Ito R, Kitadai Y, Kyo E et al: Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res, 1993; 53: 4102-6
28. Chen Z, Colon I, Oitiz N et al: Effects of interleukin-1 alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res, 1998; 58: 3668-76
29. Wolf JS, Chen Z, Dong G et al: IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res, 2001; 7: 1812-20
30. 2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem, 1996; 271: 8307-12
31. Hofmeister R, Wiegmann K, Korherr C et al: Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem. 1997; 272: 27730-36
32. Anthonsen MW, Andersen S, Solhaug A, Johansen B: Atypical lambda/iota PKC conveys 5-lipoxygenase/leukotriene B4-mediated cross-talk between phospliolipase A2s regulating NF-κB activation in response to tumor necrosis factor-α and interleukin-1β. J Biol Chem 2001;276:35344-51
33. Jung YD, Fan F, McConkey DJ et al: Role of P38 MAPK, AP-1, and NF-κB in interleukin-1β-induced IL-8 expression in human vascular smooth muscle cells. Cytokine. 2002; 8: 206-13
34. Kawaguchi M, Akagi M, Gray MJ et al: Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1beta. Surgery, 2004; 136: 686-92
35. Jang BC, Lim KJ, Paik JH et al: Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. Biochem Biophys Res Commun. 2004; 320: 1026-33
36. Banasiewicz T, Paszkowski J, Wierzbicki T et al: Proliferative activity of metastatic liver tumors based on the evaluation of MAPK sub-unit p42s activity. Med Sci Monit, 1999; 5(6): 1070-73
37. Martin MU, Falk W: The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur Cytokine Netw, 1997; 8: 5-17
38. Guan Z, Baier LD, Morrison AR: p38 mitogen-activated protein kinase down-regulates nitric oxide and lip-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β. J Biol Clin, 1997; 272: 8083-89
39. Wang C, Wang MW, Tashiro S T et al: Evodiamine induced human melanoma A375-S2 cell death partially through interleukin-1 mediated pathway. Biol Pharm Bull, 2005; 28: 984-89
40. Shin EY, Kim SY, Kim EG: c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp Mol Med, 2001; 33: 276-83
41. Kida K, Kobayashi M, Suzuki T T et al: Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine, 2005; 29: 159-68
42. Harris GK, Shi X: Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutat Res, 2003; 533: 183-200
43. Kamińska T, Szuster-Ciesielska A, Wysocka A et al: Semin cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hvpersensitivity to neuroleptics. Med Sci Monit, 2003; 9(7): CS71-CS75
44. Wu LL, Chiou CC, Chang PY, Wu JT: Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta, 2004; 339: 1-9
45. Rutkowska M, Strzyzewski K, Iskra M et al: Increased protein carbonyl groups in the serum of men with chronic arterial occlusion and the effect of postoperative treatment. Med Sci Monit, 2005; 11(2): CR79-CR83
46. Cheng ZJ, Vapaatalo H, Mervaala E: Angiotensin II and vascular inflammation. Med Sci Monit. 2005; 11(6): RA194-RA205
47. Duval C, Cantero AV, Auge N et al: Proliferation and wound healing of vascular cells trigger the generation of extracellular reactive oxygen species and LDL oxidation. Free Radic Biol Med, 2003; 35: 1589-98
48. Lo YY, Conquer JA, Grinstein S, Cruz TF: Interleukin-1β induction of c-fos and collagenase expression in articular chondrocytes: involvement of reactive oxygen species. J Cell Biochem, 1998; 69: 19-29
49. 2,-generating NADH oxidase in human lung fibroblasts by transfomiing growth factor β1. J Biol Chem, 1995; 270: 30334-38
50. Sizemore N, Leung S, Stark GR: Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphotylation and activation of the NF-κB p65/RelA subunit. Mol Cell Biol. 1999; 19: 1798-805
51. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995; 1: 27-31
52. Hirschi KK, D'Amore PA: Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS, 1997; 79: 419-28
53. Goede V, Schmidt T, Kimmina S et al: Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest. 1998; 78: 1385-94